![](/images/general/no_picture/200_user.png)
Jon D Hoffmann
Examiner (ID: 9303, Phone: (571)272-9916 , Office: P/3746 )
Most Active Art Unit | 3746 |
Art Unit(s) | 3746 |
Total Applications | 82 |
Issued Applications | 44 |
Pending Applications | 0 |
Abandoned Applications | 38 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6433467
[patent_doc_number] => 20100152304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING PERIPLANETA AMERICANA OR ITS ETHANOL EXTRACT AND A METHOD OF USING THE SAME FOR TREATING INFLAMMATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/336675
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12336675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/336675 | PHARMACEUTICAL COMPOSITION COMPRISING PERIPLANETA AMERICANA OR ITS ETHANOL EXTRACT AND A METHOD OF USING THE SAME FOR TREATING INFLAMMATIONS | Dec 16, 2008 | Abandoned |
Array
(
[id] => 5480758
[patent_doc_number] => 20090203715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'NOVEL 2-HETARYLTHIAZOLE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE AS PHARMACEUTICALS'
[patent_app_type] => utility
[patent_app_number] => 12/331028
[patent_app_country] => US
[patent_app_date] => 2008-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10984
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203715.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331028 | 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals | Dec 8, 2008 | Issued |
Array
(
[id] => 5993615
[patent_doc_number] => 20110015268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/746052
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1983
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746052
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746052 | Pharmaceutical composition | Dec 4, 2008 | Issued |
Array
(
[id] => 5331347
[patent_doc_number] => 20090111824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5'
[patent_app_type] => utility
[patent_app_number] => 12/258169
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7688
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111824.pdf
[firstpage_image] =>[orig_patent_app_number] => 12258169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/258169 | AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5 | Oct 23, 2008 | Abandoned |
Array
(
[id] => 5564778
[patent_doc_number] => 20090137631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF G- AND/OR GC-RICH NUCLEIC ACID EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/256477
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12093
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137631.pdf
[firstpage_image] =>[orig_patent_app_number] => 12256477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/256477 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF G- AND/OR GC-RICH NUCLEIC ACID EXPRESSION | Oct 22, 2008 | Abandoned |
Array
(
[id] => 7818652
[patent_doc_number] => 20120065272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'NOVEL USE OF PANDURATIN DERIVATIVES OR EXTRACT OF KAEMPFERIA PANDURATA COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/738591
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9814
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738591 | NOVEL USE OF PANDURATIN DERIVATIVES OR EXTRACT OF KAEMPFERIA PANDURATA COMPRISING THE SAME | Oct 16, 2008 | Abandoned |
Array
(
[id] => 6267674
[patent_doc_number] => 20100298396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/738372
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25569
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298396.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738372 | Manufacture, compositions and uses of coagulation factor VIIa modulator | Oct 15, 2008 | Issued |
Array
(
[id] => 6516673
[patent_doc_number] => 20100216848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'LIQUID PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION OF A SUBSTITUTED AMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/678783
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6522
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678783 | LIQUID PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION OF A SUBSTITUTED AMIDE | Oct 5, 2008 | Abandoned |
Array
(
[id] => 6379847
[patent_doc_number] => 20100081862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Composition and method to modify sperm function and increase male gender ratio in mammals'
[patent_app_type] => utility
[patent_app_number] => 12/286521
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4877
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12286521
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286521 | Composition and method to modify sperm function and increase male gender ratio in mammals | Sep 30, 2008 | Abandoned |
Array
(
[id] => 6391197
[patent_doc_number] => 20100303739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Highly Concentrated Fatty Alcohol Sulfate Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/678041
[patent_app_country] => US
[patent_app_date] => 2008-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2069
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303739.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678041 | Highly Concentrated Fatty Alcohol Sulfate Preparation | Sep 5, 2008 | Abandoned |
Array
(
[id] => 11229769
[patent_doc_number] => 09456980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Latanoprost-containing aqueous pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 12/674962
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5025
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12674962
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674962 | Latanoprost-containing aqueous pharmaceutical composition | Aug 28, 2008 | Issued |
Array
(
[id] => 9250476
[patent_doc_number] => 08614255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Pulmonary pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 12/195878
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11732
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12195878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195878 | Pulmonary pharmaceutical formulations | Aug 20, 2008 | Issued |
Array
(
[id] => 4960576
[patent_doc_number] => 20080275001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER'
[patent_app_type] => utility
[patent_app_number] => 12/172707
[patent_app_country] => US
[patent_app_date] => 2008-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10718
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172707
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172707 | Solid oral dosage form containing an enhancer | Jul 13, 2008 | Issued |
Array
(
[id] => 5496469
[patent_doc_number] => 20090264497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-COA REDUCTASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/172143
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3951
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172143 | STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-COA REDUCTASE INHIBITOR | Jul 10, 2008 | Abandoned |
Array
(
[id] => 6231814
[patent_doc_number] => 20100184783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY ATHEROSCLEROSIS COMPRISING A MAST CELL INHIBITOR AND A PPAR GAMMA AGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/452596
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18271
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452596
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452596 | COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY ATHEROSCLEROSIS COMPRISING A MAST CELL INHIBITOR AND A PPAR GAMMA AGONIST | Jun 24, 2008 | Abandoned |
Array
(
[id] => 9375843
[patent_doc_number] => 08680107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Activators and therapeutic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 12/665473
[patent_app_country] => US
[patent_app_date] => 2008-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6168
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665473 | Activators and therapeutic applications thereof | Jun 18, 2008 | Issued |
Array
(
[id] => 8896936
[patent_doc_number] => 08476458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Methods and compositions for modulating P300/CBP activity'
[patent_app_type] => utility
[patent_app_number] => 12/665751
[patent_app_country] => US
[patent_app_date] => 2008-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 19373
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665751 | Methods and compositions for modulating P300/CBP activity | Jun 18, 2008 | Issued |
Array
(
[id] => 5515533
[patent_doc_number] => 20090215840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'METHODS FOR TREATING SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 12/136099
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 13595
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215840.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136099 | Methods for treating schizophrenia | Jun 9, 2008 | Issued |
Array
(
[id] => 6134563
[patent_doc_number] => 20110008465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SESQUITERPENE FORMULATIONS, KITS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/602382
[patent_app_country] => US
[patent_app_date] => 2008-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 16495
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008465.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602382 | SESQUITERPENE FORMULATIONS, KITS AND METHODS OF USE THEREOF | Jun 1, 2008 | Abandoned |
Array
(
[id] => 6509698
[patent_doc_number] => 20100210700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/598012
[patent_app_country] => US
[patent_app_date] => 2008-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17424
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210700.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598012
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598012 | METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE | May 6, 2008 | Abandoned |